Monday, December 11, 2006

DIGE Gets big boost from CDC

http://biz.yahoo.com/prnews/061211/nym066.html?.v=64

To quote the story:
The CDC states that "molecular tests can be used to detect HPV DNA. The only such test that is currently approved by the FDA is Digene's Hybrid CaptureĀ® II HPV Test." The DigeneĀ® HPV Test is approved in the United States for routine screening of all women age 30 and older, along with the Pap, as well as for follow-up evaluation of women of all ages with inconclusive Pap results.
"In international cross-sectional studies that examined both cytology (Pap testing) and the HPV DNA test, the sensitivity of a single Pap test for identifying CIN 2 or 3 (cervical disease) or cancer ranged from 33 percent to 94 percent, (while) adding the HPV DNA test to conventional cytology increased the sensitivity to 87 percent to 100 percent," the document states. "Women who are HPV DNA negative and cytology negative are at very low risk of having CIN 2 or 3 or for developing it."

To boil it down
1. CDC for the first time acknowledges benefit of HPV test
2. The only approved test is DIGE's

1 Comments:

Anonymous Anonymous said...

What do you read from ATW's earnings and CC? What is the stop price and when do you recommend disposing it? Thanks!

5:44 AM  

Post a Comment

Subscribe to Post Comments [Atom]

<< Home